RxDoctor Payments Data

Mukul Mehra

Gastroenterology · Birmingham, ALNPI 1821053455

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $165,890 of the $193,184 with a category attached, or 85.9%. AbbVie accounts for 67.2% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $111,970 and has fallen 99.9% since, to $80 in 2025. Among gastroenterology clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$193,184in general payments, 2019–2025

Across 299 payments — averaging $646.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$130K
  • Gilead$57K
  • Intercept Pharmaceuticals, Inc.$5K
  • Johnson & Johnson$279
  • Romark Laboratories, LC$251
  • Takeda Pharmaceuticals U.S.A., Inc.$185
  • plus $592 from 12 others

What the payments were for

  • Consulting fees$190%
  • Speaking & faculty fees$165,89086%
  • Travel & lodging$22,11111%
  • Food & beverage$5,1363%
  • Education$150%
  • Entertainment$130%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$193,184 in reported general payments places this provider in the 95th percentile of 225 gastroenterology providers in Alabama.

See all gastroenterology providers in Alabama

Other gastroenterology in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →